Profile
Mr. Stephen M.
Hahn is a Chief Executive Officer at Nucleus Radiopharma, Inc. He is on the Board of Directors at Ion Beam Applications SA and Faeth Therapeutics, Inc. He received his undergraduate degree from William Marsh Rice University and a graduate degree from Temple University (Pennsylvania).
Stephen Hahn active positions
| Companies | Position | Start |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Director/Board Member | 2026-06-15 |
| FAETH THERAPEUTICS, INC. | Director/Board Member | 2026-06-11 |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Chief Executive Officer | 2025-08-19 |
Training of Stephen Hahn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
- Stock Market
- Insiders
- Stephen Hahn
















